Literature DB >> 14576768

Cyclin D3 and c-MYC control glucocorticoid-induced cell cycle arrest but not apoptosis in lymphoblastic leukemia cells.

M J Ausserlechner1, P Obexer, G Böck, S Geley, R Kofler.   

Abstract

Glucocorticoids (GC) induce cell cycle arrest and apoptosis in lymphoblastic leukemia cells. To investigate cell cycle effects of GC in the absence of obscuring apoptotic events, we used human CCRF-CEM leukemia cells protected from cell death by transgenic bcl-2. GC treatment arrested these cells in the G1 phase of the cell cycle due to repression of cyclin D3 and c-myc. Cyclin E and Cdk2 protein levels remained high, but the kinase complex was inactive due to increased levels of bound p27(Kip1). Conditional expression of cyclin D3 and/or c-myc was sufficient to prevent GC-induced G1 arrest and p27(Kip1) accumulation but, importantly, did not interfere with the induction of apoptosis. The combined data suggest that repression of both, c-myc and cyclin D3, is necessary to arrest human leukemia cells in the G1 phase of the cell division cycle, but that neither one is required for GC-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14576768     DOI: 10.1038/sj.cdd.4401328

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  18 in total

1.  Dose-dependent effects of stable cyclin B1 on progression through mitosis in human cells.

Authors:  Frank Wolf; Cornelia Wandke; Nina Isenberg; Stephan Geley
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

2.  Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia.

Authors:  Shuo-Chieh Wu; Loretta S Li; Nadja Kopp; Joan Montero; Bjoern Chapuy; Akinori Yoda; Amanda L Christie; Huiyun Liu; Alexandra Christodoulou; Diederik van Bodegom; Jordy van der Zwet; Jacob V Layer; Trevor Tivey; Andrew A Lane; Jeremy A Ryan; Samuel Y Ng; Daniel J DeAngelo; Richard M Stone; David Steensma; Martha Wadleigh; Marian Harris; Emeline Mandon; Nicolas Ebel; Rita Andraos; Vincent Romanet; Arno Dölemeyer; Dario Sterker; Michael Zender; Scott J Rodig; Masato Murakami; Francesco Hofmann; Frank Kuo; Michael J Eck; Lewis B Silverman; Stephen E Sallan; Anthony Letai; Fabienne Baffert; Eric Vangrevelinghe; Thomas Radimerski; Christoph Gaul; David M Weinstock
Journal:  Cancer Cell       Date:  2015-07-13       Impact factor: 31.743

3.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

4.  Establishing a sensitive and specific assay for determination of glucocorticoid bioactivity.

Authors:  Bastian Oppl; Anita Kofler; Siegfried Schwarz; Johannes Rainer; Reinhard Kofler
Journal:  Wien Klin Wochenschr       Date:  2011-04-07       Impact factor: 1.704

5.  The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression.

Authors:  Judith Hagenbuchner; Michael J Ausserlechner; Verena Porto; Reinhard David; Bernhard Meister; Martin Bodner; Andreas Villunger; Kathrin Geiger; Petra Obexer
Journal:  J Biol Chem       Date:  2010-01-05       Impact factor: 5.157

6.  Repression of BIRC5/survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA damage-induced apoptosis.

Authors:  Petra Obexer; Judith Hagenbuchner; Thomas Unterkircher; Nora Sachsenmaier; Christoph Seifarth; Günther Böck; Verena Porto; Kathrin Geiger; Michael Ausserlechner
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

7.  GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling.

Authors:  Emira Ayroldi; Ornella Zollo; Alessandra Bastianelli; Cristina Marchetti; Massimiliano Agostini; Rosa Di Virgilio; Carlo Riccardi
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808

Review 8.  Regulation of Bim in Health and Disease.

Authors:  Ronit Vogt Sionov; Spiros A Vlahopoulos; Zvi Granot
Journal:  Oncotarget       Date:  2015-09-15

Review 9.  Pharmacogenetics in acute lymphoblastic leukemia.

Authors:  Meyling H Cheok; Nicolas Pottier; Leo Kager; William E Evans
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

10.  Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells.

Authors:  Esther Hulleman; Karin M Kazemier; Amy Holleman; David J VanderWeele; Charles M Rudin; Mathilde J C Broekhuis; William E Evans; Rob Pieters; Monique L Den Boer
Journal:  Blood       Date:  2008-10-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.